Aldeyra Therapeutics' (ALDX) CEO Todd Brady on COVID-19 Development Update Conference Call - TranscriptSeeking Alpha • 05/20/20
Covid-19 Report: The Next Remdesivir? Aldeyra Therapeutics Is Working On ItInvestors Business Daily • 05/20/20
Aldeyra Therapeutics Inc (ALDX) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 05/13/20
Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20
Aldeyra Therapeutics announces positive early results in trial of dry eye disease treatmentMarket Watch • 12/03/19
Aldeyra Therapeutics Continues To Make Progress In Big Potential Markets Despite Stock WeaknessSeeking Alpha • 11/21/19
Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/11/19
Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Aldeyra shares slide 29% premarket after trial of eye disease treatment fails to meet goalsMarket Watch • 06/25/19
Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19